Jiang et al. reported that bufalin exerted time-dependent anti-proliferative effects on A459 non-small-cell lung cancer (NSCLC) cells, reducing cell viability by enhancing the expression of p53 and p21 (WAF1/CIP1) genes in A549 cells [37]. Here, CDKN1A is linked to non-small cell lung carcinoma.